Welcome to our dedicated page for Ardent Health news (Ticker: ARDT), a resource for investors and traders seeking the latest updates and insights on Ardent Health stock.
Ardent Health, Inc. (NYSE: ARDT) is a healthcare company in the medical care facilities sector that operates 30 acute care hospitals and approximately 280 sites of care across six states. Its news flow provides insight into how the company manages hospital operations, finances and growth initiatives in growing mid-sized urban communities in the United States.
News about Ardent Health frequently centers on its quarterly earnings releases, where the company reports total revenue, net income or net loss attributable to Ardent Health, and non-GAAP measures such as Adjusted EBITDA and Adjusted EBITDAR. These releases also present operating statistics, including admissions, adjusted admissions, inpatient and outpatient surgeries, total surgeries, emergency room visits and net patient service revenue per adjusted admission. Commentary in these reports discusses factors such as demand trends, professional fee expenses, payor denials and accounting estimate changes.
Investors following ARDT news will also see announcements about financial guidance, where Ardent Health provides ranges for full-year total revenue, net income attributable to the company, Adjusted EBITDA, rent expense payable to REITs, diluted earnings per share, adjusted admissions growth, net patient service revenue per adjusted admission growth and capital expenditures. The company’s releases explain that this guidance is based on current plans and expectations and is subject to risks and uncertainties.
Other news items include capital structure updates, such as the amendment and extension of its term loan facility and asset-based lending credit agreement, and the authorization of a $50.0 million stock repurchase program by its board of directors. Ardent Health also issues releases about participation in healthcare and investor conferences, leadership changes and the appointment of executives to roles focused on development and strategic growth.
This ARDT news page aggregates these announcements so readers can review Ardent Health’s earnings reports, guidance updates, financing actions, governance developments and conference participation in one place.
TruLite Health, developer of health equity solutions, has expanded its leadership team with key appointments. Walter D. Conwell, MD, MBA, former chief diversity officer at Morehouse School of Medicine, has been appointed as president. The company also added two board members: Edmondo Robinson, MD, MBA, a digital health leader and Ardent Health Services board member, and Caleb DesRosiers, JD, MPA, a pharmaceutical executive.
TruLite's main product, Truity™, is software that integrates with electronic health records to address clinical bias at the point of care. The solution uses explainable AI and machine learning to drive patient-specific clinical, social, and behavioral interventions, aiming to improve healthcare outcomes and costs. The software aligns with regulatory requirements from the Joint Commission, CMS, and FDA.
Ardent Health (NYSE: ARDT) has scheduled its fourth quarter and full year 2024 financial results announcement for Wednesday, February 26, 2025, after market close. The company will host a conference call and webcast on Thursday, February 27, 2025, at 9:00 a.m. ET to discuss the results and conduct a Q&A session.
The webcast and presentation materials will be accessible through Ardent's Investor Relations website at ir.ardenthealth.com. Participants are advised to register 15 minutes before the scheduled start time. The teleconference replay will be available until March 13, 2025, through both domestic and international dial-in numbers.
Ardent Health (NYSE: ARDT) has announced the acquisition of 18 urgent care clinics from NextCare Urgent Care, expanding its presence in New Mexico and Oklahoma. The transaction includes six clinics in New Mexico, which will operate under Lovelace Health System, and 12 clinics in Oklahoma under Hillcrest HealthCare System.
This strategic expansion enhances Ardent's consumer-focused healthcare ecosystem and follows their recent acquisition of nine urgent care centers in East Texas and Topeka, Kansas in 2024. The company currently operates five hospitals and 25 sites of care in New Mexico, along with eight hospitals and 57 sites of care in Oklahoma. The financial terms of the acquisition were not disclosed.
Ardent Health (NYSE: ARDT) has announced its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 13-16, 2025. The company's management team will deliver a presentation on Tuesday, January 14, 2025, at 2:15 p.m. PT.
Investors can access a live audio webcast of the presentation through Ardent Health's investor relations website at ir.ardenthealth.com, with the recording remaining available for 90 days afterward. The management team will also be conducting one-on-one meetings with registered conference attendees, which can be arranged through J.P. Morgan representatives.
Ardent Health (NYSE: ARDT) announced that seven of its facilities have been named among Top Teaching Hospitals and Top Rural Hospitals by The Leapfrog Group, one of the most competitive healthcare awards in America. The recognized facilities include four Top Teaching Hospitals: Heart Hospital of New Mexico, Hillcrest Hospital South, Hillcrest Medical Center, and Seton Medical Center Harker Heights; and three Top Rural Hospitals: Hillcrest Hospital Pryor, UT Health Carthage, and UT Health Pittsburg.
Out of nearly 2,400 hospitals considered, only 134 were selected as Top Hospitals across different categories. The award evaluates various aspects of hospital performance, including infection rates, safer surgery practices, maternity care, and medication error prevention capabilities.
Ardent Health (NYSE: ARDT) announced that nine of its facilities earned an 'A' Hospital Safety Grade from The Leapfrog Group. The grades are based on over 30 performance measures related to patient safety. 81% of Ardent's eligible facilities earned an 'A' or 'B' grade, significantly outperforming the national average of 56%. The recognized facilities include medical centers in New Jersey, Oklahoma, Idaho, and Texas. The Leapfrog Hospital Safety Grade evaluates preventable medical errors, infections, and injuries, with grades updated biannually.
Ardent Health (NYSE: ARDT) reported strong Q3 2024 results with total revenue increasing 5.2% to $1.45 billion. Net income reached $26 million ($0.19 per share), while Adjusted EBITDA grew 15.3% to $98 million with margin expansion of 50bps to 6.7%. The company saw a 3.8% increase in adjusted admissions and 0.9% growth in net patient service revenue per adjusted admission. Based on strong performance, Ardent raised its full-year 2024 guidance, increasing the Adjusted EBITDA midpoint by 2% and improving revenue outlook to $5.8-5.875 billion.
Ardent Health (NYSE: ARDT) announced its management team's participation in three upcoming investor conferences. The team will attend the Stephens Annual Investment Conference on November 19 in Nashville, featuring a fireside chat at 10:00 a.m. ET, the Citi 2024 Global Healthcare Conference on December 3 in Miami, and the Bank of America Securities Leveraged Finance Conference on December 4 in Boca Raton.
Live audio webcasts of fireside discussions will be available on Ardent Health's Investor Relations website, with replays accessible for 90 days. The management team will also conduct one-on-one meetings with registered investors at each conference.
Ardent Health (NYSE: ARDT) has scheduled its third quarter 2024 financial results announcement for Wednesday, November 6, 2024, after market close. The company will host a conference call and webcast on Thursday, November 7, 2024, at 9:00 a.m. ET to discuss the results and conduct a Q&A session. The webcast and presentation materials will be accessible through Ardent's investor relations website. A replay of the teleconference will be available until November 14, 2024.
Ardent Health has partnered with Qventus to optimize its robotics program and drive strategic surgical growth using AI-powered solutions. Qventus' Perioperative Solution intelligently markets operating room (OR) time to surgeons based on strategic objectives and personalized patterns, ensuring optimal surgery scheduling. This approach has delivered a 7x annualized ROI for Ardent.
The solution addresses common OR efficiency challenges, such as underutilization and misutilization of capacity. It prioritizes strategic cases, empowers surgeons to release unused block time early, enables precision open time marketing, and provides actionable market insights. Ardent chose Qventus for its ability to deliver significant ROI quickly and analyze market data for customized insights.
This partnership aims to improve patient access to timely surgeries across Ardent's U.S. communities while driving strategic growth for the health system.